Versor Investments LP Purchases 3,761 Shares of Tenet Healthcare Co. (NYSE:THC)

Versor Investments LP raised its position in Tenet Healthcare Co. (NYSE:THC) by 69.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,200 shares of the company’s stock after purchasing an additional 3,761 shares during the period. Versor Investments LP’s holdings in Tenet Healthcare were worth $1,161,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of THC. Plato Investment Management Ltd bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth $28,000. True Wealth Design LLC bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth $38,000. Kestra Investment Management LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter worth $60,000. Wilmington Savings Fund Society FSB lifted its holdings in shares of Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock worth $66,000 after acquiring an additional 487 shares during the last quarter. Finally, Spire Wealth Management lifted its holdings in shares of Tenet Healthcare by 19.5% during the 4th quarter. Spire Wealth Management now owns 558 shares of the company’s stock worth $70,000 after acquiring an additional 91 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on THC shares. TD Cowen started coverage on shares of Tenet Healthcare in a research note on Wednesday. They issued a “buy” rating and a $175.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a research note on Friday, November 22nd. KeyCorp lowered their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Finally, Wells Fargo & Company cut shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $205.00 to $150.00 in a research report on Monday, November 25th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $163.88.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $130.48 on Friday. The stock has a market capitalization of $12.41 billion, a P/E ratio of 4.05, a P/E/G ratio of 1.02 and a beta of 2.05. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. Tenet Healthcare Co. has a 1 year low of $88.98 and a 1 year high of $171.20. The company’s 50-day moving average is $133.09 and its 200 day moving average is $147.25.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. On average, sell-side analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.